Tarsus Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
TARS Nasdaq 2834 www.tarsusrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tarsus Pharmaceuticals, Inc.

Tarsus to Participate in Upcoming Investor Conferences - May 29th, 2025 3:00 pm
Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - May 14th, 2025 7:45 am
Tarsus Pharmaceuticals, Inc. (TARS): Among the Best Breakout Stocks to Buy According to Analysts - May 5th, 2025 4:04 pm
Analysts Just Made A Substantial Upgrade To Their Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Forecasts - May 4th, 2025 6:18 am
Tarsus Pharmaceuticals Inc (TARS) Q1 2025 Earnings Call Highlights: Record Sales Surge and ... - May 2nd, 2025 1:17 am
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q1 Loss, Tops Revenue Estimates - May 1st, 2025 3:35 pm
Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements - May 1st, 2025 2:05 pm
Wall Street Analysts See a 31.89% Upside in Tarsus Pharmaceuticals (TARS): Can the Stock Really Move This High? - Apr 30th, 2025 7:55 am
Earnings Preview: Werewolf Therapeutics, Inc. (HOWL) Q1 Earnings Expected to Decline - Apr 25th, 2025 8:00 am
Tarsus to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 - Apr 24th, 2025 3:00 pm
Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (ASCRS) 2025 Annual Meeting - Apr 22nd, 2025 6:31 am
Tarsus Announces Pricing of Upsized $125.0 Million Public Offering - Mar 12th, 2025 7:49 pm
Tarsus Announces Proposed $100.0 Million Public Offering - Mar 12th, 2025 2:12 pm
Tarsus to Participate in Upcoming Investor Conference - Mar 6th, 2025 3:00 pm
Tarsus Pharmaceuticals Inc (TARS) Q4 2024 Earnings Call Highlights: Strong Sales Growth and ... - Feb 26th, 2025 12:05 am
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Tops Revenue Estimates - Feb 25th, 2025 6:40 am
Tarsus Reports Strong Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Achievements - Feb 25th, 2025 5:00 am
Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025 - Feb 20th, 2025 3:00 pm
Breakeven On The Horizon For Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) - Feb 4th, 2025 6:49 am
CRISPR Therapeutics (CRSP) Moves 6.5% Higher: Will This Strength Last? - Jan 23rd, 2025 6:30 am